In 1982, researchers discovered the first family of cancer-causing genes, which included the Kirsten rat sarcoma virus (KRAS), a gene that provides instructions for making a protein called K-Ras that relays signals from outside the cell to the cell’s nucleus. The KRAS gene is estimated to be a factor in up to 30 percent of all human cancers, including lung, pancreatic and colorectal cancer. At the time, the protein was deemed “undruggable.”
The Institute of Chemical Biology & Drug Discovery (ICB&DD) brings together researchers and scientists throughout Stony Brook University to study and investigate chemical biology and advance the field of drug discovery.
2023 RSOM Faculty Awards - Congratulations to Jessica Seeliger, Markus Seeliger, and Getu Teressa (former Pharmacology PhD and MSTP student)
The Renaissance School of Medicine has selected the winners of the 2023 Faculty Awards. Every year, the RSOM recognizes faculty members who are nominated for their outstanding work in the areas of research, teaching, clinical service, mentoring and humanism—all of which are vital facets that encompass the mission of the School of Medicine.
We are delighted to announce this year's (2023) RSOM Faculty awards:
President's Award to Distinguished Doctoral Students
Michael Martinez, Molecular And Cellular Pharmacology
Please click here for more details.
Angela Kokkosis, MD
James E. Egan, PhD
We are delighted to announce the
2022 Renaissance School of Medicine Faculty Awards winners.
Aesculapius Award for Excellence in Medical Education: Dr. Eva Swoboda, Department of Obstetrics and Gynecology
Early Career Research Excellence Award: Dr. Dongyan Tan, Department of Pharmacological Sciences, and Dr. Pawan Kumar, Department of Microbiology and Immunology